Label: CICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%. shampoo

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated May 16, 2019

If you are a consumer or patient please visit this version.

  • Directions for use

    ss

  • Sincerus Florida, LLC. Adverse reactions

    yujd

  • Active, inactive

    ww

  • NDC 72934- 7039-6 CICLOPIROX OLAMINE USP 0.77% / CLOBETASOL PROPIONATE USP 0.05% / SALICYLIC ACID USP 3%. Shampoo 120gm

    ad

  • INGREDIENTS AND APPEARANCE
    CICLOPIROX OLAMINE 0.77% / CLOBETASOL PROPIONATE 0.05% / SALICYLIC ACID 3%. 
    ciclopirox olamine 0.77% / clobetasol propionate 0.05% / salicylic acid 3%. shampoo
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-7039
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID3 g  in 100 g
    CICLOPIROX OLAMINE (UNII: 50MD4SB4AP) (CICLOPIROX - UNII:19W019ZDRJ) CICLOPIROX1 g  in 100 g
    CLOBETASOL PROPIONATE (UNII: 779619577M) (CLOBETASOL - UNII:ADN79D536H) CLOBETASOL PROPIONATE0.05 g  in 100 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72934-7039-6120 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/17/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/17/2019
    Labeler - Sincerus Florida, LLC (080105003)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sincerus Florida, LLC080105003manufacture(72934-7039)